Evidence map›Paper›PMID 30609803›Full record

ReviewToxins2019

Evolutionary Features in the Structure and Function of Bacterial Toxins.

Raj Kumar, Thomas M Feltrup, Roshan V Kukreja, Kruti B Patel, Shuowei Cai, Bal Ram Singh

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Unveiling the pathogenic mechanisms ofEmerging microbes & infections · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. ABToxins · 2022
    Review
  9. Frontiers in molecular biosciences · 2022
    Article
  10. Review
  11. Article
  12. Nanopore sensing: A physical-chemical approach.Biochimica et biophysica acta. Biomembranes · 2021
    Review
  13. Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins?International journal of molecular sciences · 2020
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Raj KumarBotulinum Research Center, Institute of Advanced Sciences, Dartmouth, MA 02747, USA. rkumar@inads.org.
Thomas M FeltrupBotulinum Research Center, Institute of Advanced Sciences, Dartmouth, MA 02747, USA. tfeltrup@gmail.com.
Roshan V KukrejaBotulinum Research Center, Institute of Advanced Sciences, Dartmouth, MA 02747, USA. rv307@yahoo.com.
Kruti B PatelBotulinum Research Center, Institute of Advanced Sciences, Dartmouth, MA 02747, USA. kruti.vasa@gmail.com.
Shuowei CaiDepartment of Chemistry and Biochemistry, University of Massachusetts, Dartmouth, MA 02747, USA. swcai@aol.com.
Bal Ram SinghBotulinum Research Center, Institute of Advanced Sciences, Dartmouth, MA 02747, USA. bsingh@inads.org.
University of Massachusetts Dartmouth · US

Funding

A novel and innovative approach for axonal regeneration after Spinal Cord Injury (SCI)R03NS108074 · NINDS · INSTITUTE OF ADVANCED SCIENCES, INC. · PI KUMAR, RAJ, SINGH, BAL RAM · 2018 to 2019
$110k
NINDS NIH HHS R03 NS108074
6 · The paper itself

Abstract

Toxins can function both as a harmful and therapeutic molecule, depending on their concentrations. The diversity in their function allows us to ask some very pertinent questions related to their origin and roles: (a) What makes them such effective molecules? (b) Are there evolutionary features encoded within the structures of the toxins for their function? (c) Is structural hierarchy in the toxins important for maintaining their structure and function? (d) Do protein dynamics play a role in the function of toxins? and (e) Do the evolutionary connections to these unique features and functions provide the fundamental points in driving evolution? In light of the growing evidence in structural biology, it would be appropriate to suggest that protein dynamics and flexibility play a much bigger role in the function of the toxin than the structure itself. Discovery of IDPs (intrinsically disorder proteins), multifunctionality, and the concept of native aggregation are shaking the paradigm of the requirement of a fixed three-dimensional structure for the protein's function. Growing evidence supporting the above concepts allow us to redesign the structure-function aspects of the protein molecules. An evolutionary model is necessary and needs to be developed to study these important aspects. The criteria for a well-defined model would be: (a) diversity in structure and function, (b) unique functionality, and (c) must belong to a family to define the evolutionary relationships. All these characteristics are largely fulfilled by bacterial toxins. Bacterial toxins are diverse and widely distributed in all three forms of life (Bacteria, Archaea and Eukaryotes). Some of the unique characteristics include structural folding, sequence and functional combination of domains, targeting a cellular process to execute their function, and most importantly their flexibility and dynamics. In this work, we summarize certain unique aspects of bacterial toxins, including role of structure in defining toxin function, uniqueness in their enzymatic function, and interaction with their substrates and other proteins. Finally, we have discussed the evolutionary aspects of toxins in detail, which will help us rethink the current evolutionary theories. A careful study, and appropriate interpretations, will provide answers to several questions related to the structure-function relationship of proteins, in general. Additionally, this will also allow us to refine the current evolution theories.

Indexed as

Bacterial ToxinsEvolution, MolecularHumansProteinsBacterial ToxinsProteinsADP-ribosylationanthrax toxinbacterial toxinbotulinum toxincholera toxinevolutiongluzincin clansnare proteins

Identifiers

PMID30609803
PMCPMC6356308
OpenAlexW2907594772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.